SCHEMBL4143167

SCHEMBL4143167

CC(C)C(C(=O)O)N1C(=O)C(=CC=Cc2ccccc2)SC1=S

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 11/20 0.72
▸ MEN1 O00255 9/20 0.72
▸ KMT2A Q03164 9/20 0.72
▸ ALDH1A1 P00352 7/20 0.72
▸ POLB P06746 6/20 0.72
▸ THRB P10828 4/20 0.72
▸ RECQL P46063 4/20 0.72
▸ TDP1 Q9NUW8 4/20 0.72
▸ L3MBTL1 Q9Y468 4/20 0.72
▸ KDM4E B2RXH2 3/20 0.72
▸ USP2 O75604 3/20 0.72
▸ BLM P54132 3/20 0.72
▸ HPGD P15428 2/20 0.72
▸ APEX1 P27695 2/20 0.72
▸ PTPN22 Q9Y2R2 2/20 0.72
▸ CYP3A4 P08684 1/20 0.72
▸ CYP2C9 P11712 1/20 0.72
▸ ALOX12 P18054 1/20 0.72
▸ TNNI3 P19429 1/20 0.72
▸ CYP2C19 P33261 1/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13852445 1.00 MAPT (0.72) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL2778876 0.88 MAPT (0.71) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL19425711 0.88 MAPT (0.71) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL5970105 0.87 BCL2 (0.80) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL5970104 0.87 BCL2 (0.80) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL13852446 0.85 DUSP3 (0.64) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL14680229 0.84 MAPT (1.00) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL13852582 0.81 MAPT (1.00) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL2789751 0.81 MAPT (1.00) MAPTMEN1KMT2AALDH1A1POLB
SCHEMBL13657864 0.81 MAPT (1.00) MAPTMEN1KMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090124675-A1 INHIBITORS OF ANTI-APOPTOTIC PROTEINS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2009-05-14 — — US claimed
US-20090124675-A1 INHIBITORS OF ANTI-APOPTOTIC PROTEINS BURNHAM INSTITUTE FOR MEDICAL RESEARCH (US) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124675-A1 INHIBITORS OF ANTI-APOPTOTIC PROTEINS BAX, BCL2, BAK1 MAPT 3907/4885MEN1 4293/4885KMT2A 4499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback